• Western blot analysis of 3T3 lysate, antibody was diluted at 1000. Secondary antibody was diluted at 1:20000

Anti-RRN3 antibody (STJ99630)

SKU:
STJ99630

Current Stock:
Host: Rabbit
Applications: WB/IHC
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-RNA polymerase I-specific transcription initiation factor RRN3 is suitable for use in Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: RRN3
Gene ID: 54700
Uniprot ID: RRN3_HUMAN
Specificity: This antibody detects endogenous levels of TIF-IA.
Immunogen: Synthesized peptide derived from the human TIF-IA Polyclonal
Function Required for efficient transcription initiation by RNA polymerase I. Required for the formation of the competent preinitiation complex (PIC). Dissociates from pol I as a consequence of transcription. In vitro, cannot activate transcription in a subsequent transcription reaction.
Protein Name Rna Polymerase I-Specific Transcription Initiation Factor Rrn3
Transcription Initiation Factor Ia
Tif-Ia
Database Links Reactome: R-HSA-73762
Reactome: R-HSA-73772
Cellular Localisation Nucleus
Nucleolus
Alternative Antibody Names Anti-Rna Polymerase I-Specific Transcription Initiation Factor Rrn3 antibody
Anti-Transcription Initiation Factor Ia antibody
Anti-Tif-Ia antibody
Anti-RRN3 antibody
Anti-TIFIA antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance